| Literature DB >> 33982168 |
Roman Kia Rahimi-Nedjat1, Keyvan Sagheb2, Kawe Sagheb3, Maike Hormes2, Christian Walter2, Bilal Al-Nawas2.
Abstract
OBJECTIVES: To analyze the correlation of diabetes mellitus and hyperglycemia with severe odontogenic abscesses.Entities:
Keywords: Abscess treatment; Blood sugar count; Diabetes mellitus; Odontogenic abscesses
Mesh:
Substances:
Year: 2021 PMID: 33982168 PMCID: PMC8531061 DOI: 10.1007/s00784-021-03926-4
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Fig. 1Age distribution of the abscess patients in absolute numbers
Overview of age, gender ratio, and duration of hospital stay in the abscess group. Number of patients with abnormal maximum blood sugar counts (MBSC) and fasting blood sugar counts (FBSC). Distribution of the abscesses to the different compartments
| Non-diabetics | Diabetics | All | ||||
|---|---|---|---|---|---|---|
| Age (SD, min–max) | 39.4 | (±21.1, 1–93) | 61.1 | (±16.8, 20–92) | 41 | (±21.5) |
| Male | 501 | (55.3%) | 37 | (52.1%) | 538 | (55.1%) |
| Female | 405 | (44.7%) | 34 | (47.9%) | 439 | (44.9%) |
| 906 | (92.7%) | 71 | (7.3%) | 977 | (100%) | |
| Mean hospital stay (SD) | 6 days | (±3 days) | 6.4 days | (±3.3 days) | 6 days | (±3 days) |
| Type I diabetes | 6 | (8.5%) | 6 | (8.5%) | ||
| Type II diabetes | 65 | (91.5%) | 65 | (91.5%) | ||
| Medicinal treatment | 59 | 83.1%) | 59 | 83.1%) | ||
| Dietary treatment | 12 | (16.9%) | 12 | (16.9%) | ||
| Abnormal MBSC | 24 | (42.9%) | 32 | (57.4%) | 56 | (5.7%) |
| Abnormal FBSC | 17 | (47.2%) | 22 | (56.4%) | 39 | (3.9%) |
| Perimandibular | 316 | (34.9%) | 17 | (23.9%) | 333 | (34.0%) |
| Cheek | 149 | (16.5%) | 11 | (15.5%) | 160 | (16.4%) |
| Submental | 28 | (3.1%) | 11 | (15.5%) | 39 | (4.0%) |
| Paramandibular | 102 | (11.3%) | 10 | (14.1%) | 112 | (11.5%) |
| Fossa canina | 134 | (14.8%) | 10 | (14.1%) | 144 | (14.7%) |
| Submandibular | 135 | (14.9%) | 10 | (14.1%) | 145 | (14.8%) |
| Mouth base | 8 | (0.9%) | 1 | (1.4%) | 9 | (0.9%) |
| Palatal | 11 | (1.2%) | 1 | (1.4%) | 12 | (1.2%) |
| Retromaxillar | 10 | (1.2%) | 1 | (1.4%) | 11 | (1.1%) |
| Parapharynx | 1 | (0.1%) | 1 | (0.1%) | ||
| Retropharynx | 12 | (1.3%) | 12 | (1.2%) | ||
Fig. 2Involved compartments in absolute numbers
Mean FBSC and MBSC counts for patients from the abscess group (a) and patients from the general group (g). Values in mg/dl and standard deviation in brackets
| FBSC (mean ±SD) | FBSC (min–max) | MBSC (mean ±SD) | MBSC (min–max) | |
|---|---|---|---|---|
| All (a) | 114.0 ±73.2 | 43–478 | 112.9 ±71.4 | 39–784 |
| Diabetics (a) | 154.5 ±76.7 | 80–394 | 243.1 ±145.2 | 64–784 |
| Non-diabetics (a) | 101 ±64.1 | 43–478 | 101.9 ±47.2 | 39–655 |
| all (g) | 105.7 ±44.1 | 30–350 | 109.0 ±73.5 | 34–600 |
| Diabetics (g) | 137.0 ±62.8 | 30–350 | 231.0 ±114.5 | 76–600 |
| Non-diabetics (g) | 90.0 ±33.8 | 50–267 | 107.1 ±63.2 | 34–600 |
Overview of age, gender ratio, and duration of hospital stay in the general group (non-abscess patients). Number of patients with abnormal maximum blood sugar counts (MBSC) and fasting blood sugar counts (FBSC)
| Non-diabetics | Diabetics | All | ||||||
|---|---|---|---|---|---|---|---|---|
| Age (SD) | 49.9 | (±22.9) | 69.2 | (±13.2) | 50.1 | (±22.9) | ||
| Male (%) | 1260 | (59%) | 81 | (66.9%) | 1341 | (59.4%) | ||
| Female (%) | 877 | (41%) | 40 | (32.5%) | 917 | (40.6%) | ||
| 2137 | (94.6%) | 121 | (5.3%) | 2258 | (100%) | |||
| Mean hospital stay | 3 days | (±5.4 days) | 7 days | (±6.9 days) | 3 days | (±5.5 days) | ||
| Type I diabetes | 4 | (3.3%) | 4 | (3.3%) | ||||
| Type II diabetes | 117 | (96.7%) | 117 | (96.7%) | ||||
| Dietary treatment | 28 | (23.1%) | 28 | (23.1%) | ||||
| Medicinal treatment | 93 | (76.9%) | 93 | (76.9%) | ||||
| Abnormal MBSC (%) | 162 | (66.9%) | 80 | (33.1%) | 242 | (10.7%) | ||
| Abnormal FBSC (%) | 122 | (65.9%) | 63 | (34.1%) | 185 | (8.2%) | ||